Promotes transparency in prescription drug prices by establishing a Prescription Drug Affordability Board.
This bill aims to promote transparency in prescription drug prices by establishing a Prescription Drug Affordability Board within the Massachusetts Health Policy Commission. The Board will identify drugs subject to affordability reviews, conduct reviews to determine if drug costs pose affordability challenges, and set upper payment limits for drugs deemed unaffordable. The Board will also assess penalties for non-compliance and require manufacturers to submit access and affordability improvement plans.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.